Related Experiment Video
Updated: Sep 2, 2025
08:59
A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma
Published on: January 5, 2017
10.7K
Primary Cervical Carcinosarcoma: Report of a Rare Case
Georgios Tsatsaris1, Zacharias Fasoulakis2, Antonios Koutras2
1Department of Obstetrics and Gynecology, Democritus University of Thrace, Dragana, Alexandroupolis, Greece.
Surgery Journal (New York, N.Y.)
|August 5, 2022
Summary
Cervical carcinosarcomas, a rare malignant mixed Müllerian tumor (MMMT), present unique diagnostic challenges. Early diagnosis via immunochemistry is vital for effective treatment of this rare cervical cancer.
Area of Science:
- Gynecologic Oncology
- Pathology
Background:
- Malignant mixed Müllerian tumors (MMMT) are neoplasms with epithelial and mesenchymal components.
- Cervical carcinosarcomas are exceptionally rare, with fewer than 150 reported cases.
- These tumors represent a significant diagnostic and therapeutic challenge in gynecologic oncology.
Observation:
- A case of a 79-year-old postmenopausal woman presenting with pelvic mass and vaginal bleeding.
- Cervical curettage revealed a biphasic malignant neoplasm: chondrosarcoma and adenocarcinoma.
- Immunohistochemical (IHC) staining confirmed the diagnosis of MMMT.
Findings:
- The patient received neoadjuvant chemotherapy and radiotherapy.
- A subsequent radical hysterectomy and pelvic lymph node dissection were performed.
- The patient remained disease-free 12 months postoperatively.
Implications:
- Preoperative diagnosis of cervical carcinosarcoma is critical for treatment planning.
- Immunohistochemistry plays a crucial role in identifying this rare biphasic tumor.
- Multimodality treatment may lead to favorable outcomes in select cases of cervical carcinosarcoma.
